Germany: BioNTech SE and Biotheus have announced the signing of a definitive agreement for the acquisition of Biotheus, a ...
Investor's Business Daily on MSN2d
Pfizer, Moderna, BioNTech Take A Beating After Trump Taps Kennedy To Head Up HHSPfizer stock and shares of other vaccine makers slumped Friday after President-elect Donald Trump tapped Robert F. Kennedy Jr ...
The technology is expected to support the steel industry's shift to carbon neutrality by replacing coke with reduced iron in ...
Packaging company Kloeckner Pentaplast, backed by Strategic Value Partners, is reaching out to investors to raise about €2 ...
The stocks for three pharmaceutical companies heavily involved in the production of vaccines fell drastically by market close ...
RNA vaccines saved lives during the COVID-19 pandemic, but older people had less of an immune response to the vaccines than ...
With the help of TBWA\Chiat\Day New York, pharma giant Moderna is demystifying mRNA science for the average consumer. This ...
The immediate aftermath of the nomination saw vaccine stock prices drop on account of Kennedy’s well-publicized views on ...
VEGF bispecifics. | Merck and BioNTech are buying Chinese biotechs to gain PD-(L)1/VEGF bispecifics. AstraZeneca's CEO argued ...
RESEARCHERS from SINTEF have developed a “simpler” low-cost carbon capture and storage (CCS) system for sequestering ...
BioNTech to acquire clinical-stage biotech company, Biotheus to boost oncology strategy: Mainz, Germany Friday, November 15, 2024, 14:00 Hrs [IST] BioNTech SE and Biotheus (Biothe ...
The selection of vaccine sceptic Robert F Kennedy Jr by US President-elect Donald Trump to head the Department of Health and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback